Alendronate Sodium
28 NDCs across 9 manufacturers|26 Generic,2 Brand
Alendronate Sodium is used to treat postmenopausal osteoporosis and extramammary paget disease, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Sep 29, 1995, and the first generic was approved Feb 6, 2008. FDA's Orange Book lists 24 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $78 million on Alendronate Sodium across 8.8 million claims for 2.4 million beneficiaries.
Alendronate Sodium is available as 28 NDCs from 9 manufacturers (26 generic, 2 brand), with NADAC prices from $0.11 to $71.23 per EA — the most expensive product costs about 640× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
28
26G / 2B
Manufacturers
9
competing in market
Price Spread
$0.11 – $71.23
per EA, 26 of 28 NDCs
7d Activity
avg -1.2% WoW · of 28 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Amneal Pharmaceuticals of New York LLC manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Bisphosphonate class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
9 manufacturers producing ALENDRONATE SODIUM(2 pricing outliers)
Frequently Asked Questions
What is Alendronate Sodium used to treat?
Alendronate Sodium is used to treat postmenopausal osteoporosis and extramammary paget disease, per the National Library of Medicine's MED-RT classification.
When did Alendronate Sodium become available as a generic?
FDA approved the first generic Alendronate Sodium (ANDA) on Feb 6, 2008. The Orange Book currently lists 24 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Alendronate Sodium?
In 2024, Medicare Part D spent $78 million on Alendronate Sodium across 8.8 million claims for 2.4 million beneficiaries.
How many Alendronate Sodium products are on the market?
The Alendronate Sodium drug market contains 28 NDCs from 9 manufacturers — 26 generic and 2 brand products.
What is the price range for Alendronate Sodium?
NADAC reference prices for Alendronate Sodium range from $0.1112 to $71.2260 per EA — the most expensive product costs about 640× the cheapest. 2 additional products are priced per different units (e.g. liquids per ML) and aren't directly comparable.
Is generic Alendronate Sodium cheaper than brand?
The average generic NADAC for Alendronate Sodium is $0.2305 per EA, versus $54.9651 for brand-labeled products — brand versions average about 238× the generic price.
Which manufacturers make Alendronate Sodium?
9 manufacturers list Alendronate Sodium in NADAC. Ranked by number of NDCs, the largest are Amneal Pharmaceuticals of New York LLC (8), NorthStar Rx LLC (6), Rising Pharma Holdings Inc. (5), Aurobindo Pharma Limited (3), Cipla USA Inc. (2).
How has the price of Alendronate Sodium changed recently?
Over the past 7 days, 2 Alendronate Sodium NDCs rose and 15 fell, with a market-wide average change of -1.2%.